CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- FinancialsAltman Z-Score 2.84: safe zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.20BCNY477.22M · vs all stocks (USD)
Revenue (TTM)
929.15MCNY138.59M · vs all stocks (USD)
Profit Margin
-22.98%vs Diagnostics & Research peers
Beta
0.4270xvs all stocks
52-Week Change
-30.97%vs all stocks
Market Capitalization
3.20BCNY477.22M · vs all stocks (USD)
Enterprise Value
3.04BCNY453.62M · vs all stocks (USD)
Forward P/E
14.37xvs Diagnostics & Research peers
Price to Sales (TTM)
3.44xvs Diagnostics & Research peers
Price to Book (MRQ)
2.25xvs Diagnostics & Research peers
Enterprise to Revenue
3.27xvs Diagnostics & Research peers
Enterprise to EBITDA
-23.59xvs Diagnostics & Research peers
Gross Margin
49.69%vs Diagnostics & Research peers
Profit Margin
-22.98%vs Diagnostics & Research peers
Operating Margin
-8.77%vs Diagnostics & Research peers
Return on Assets (TTM)
-5.18%vs Diagnostics & Research peers
Return on Equity (TTM)
-13.65%vs Diagnostics & Research peers
Revenue (TTM)
929.15MCNY138.59M · vs all stocks (USD)
Revenue per Share (TTM)
2.63CNYUpdated Sep 18, 2026Quarterly Revenue Growth
3.00%vs Diagnostics & Research peers
Gross Profit (TTM)
370.22MCNY55.22M · vs all stocks (USD)
EBITDA (TTM)
15.61MCNY2.33M · vs all stocks (USD)
Net Income (TTM)
-213.54MCNY-31.85M · vs all stocks (USD)
Operating Cash Flow (TTM)
250.98KCNY37.44K · vs all stocks (USD)
Levered Free Cash Flow (TTM)
46.63MCNY6.96M · vs all stocks (USD)
Payout Ratio
0.00%vs Diagnostics & Research peers
Minority Interest (Equity)
27.85MCNYFY2025 · Dec 31, 2025Revenue
929.82MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
528.60MCNYFY2025 · Dec 31, 2025Gross Profit
401.22MCNYFY2025 · Dec 31, 2025Operating Income
-71.18MCNY-10.62M · vs all stocks (USD)
Pre-tax Income
-189.56MCNYFY2025 · Dec 31, 2025Income Tax Expense
6.74MCNYFY2025 · Dec 31, 2025Net Income
-196.29MCNYFY2025 · Dec 31, 2025EBIT
-179.58MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
15.61MCNYFY2025 · Dec 31, 2025Research & Development
104.36MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
62.07MCNYFY2025 · Dec 31, 2025Other Operating Expenses
33.69MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
3.20MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
9.98MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.5568CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.5568CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
353.52MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
353.52MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-196.29MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-544.76KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-96.58MCNYFY2025 · Dec 31, 2025Free Cash Flow
-160.20MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
372.20MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-196.29MCNYFY2025 · Dec 31, 2025Other Non-cash Items
23.00MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
63.20MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
13.51MCNYFY2025 · Dec 31, 2025Capital Expenditures
-63.62MCNYFY2025 · Dec 31, 2025Purchase of Investments
-12.06MCNYFY2025 · Dec 31, 2025Sale of Investments
9.93MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-65.74MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
182.85MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-141.98MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-4.73MCNYFY2025 · Dec 31, 2025Other Financing Charges
-24.09MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
12.06MCNYFY2025 · Dec 31, 2025Shares Outstanding
353.52MSharesUpdated Sep 18, 2026Float Shares
259.34MSharesUpdated Sep 18, 2026% Held by Insiders
21.27%vs all stocks
% Held by Institutions
9.56%vs all stocks
Total Cash (MRQ)
238.60MCNY35.59M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.6750CNYUpdated Sep 18, 2026Total Debt (MRQ)
228.97MCNY34.15M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1575xvs Diagnostics & Research peers
Current Ratio (MRQ)
2.12xvs Diagnostics & Research peers
Book Value per Share (MRQ)
4.02CNYUpdated Sep 18, 2026Total Assets
2.28BCNY340.72M · vs all stocks (USD)
Total Current Assets
1.24BCNYFY2025 · Dec 31, 2025Total Liabilities
780.14MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.04BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
144.15MCNYFY2025 · Dec 31, 2025Total Current Liabilities
635.99MCNYFY2025 · Dec 31, 2025Cash
371.73MCNYFY2025 · Dec 31, 2025Cash Equivalents
7.78MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
379.51MCNYFY2025 · Dec 31, 2025Other Short-term Investments
2.82MCNYFY2025 · Dec 31, 2025Accounts Receivable
536.07MCNYFY2025 · Dec 31, 2025Inventory
176.76MCNYFY2025 · Dec 31, 2025Accounts Payable
272.91MCNYFY2025 · Dec 31, 2025Short-term Debt
165.87MCNYFY2025 · Dec 31, 2025Other Current Liabilities
8.55MCNYFY2025 · Dec 31, 2025Long-term Debt
107.29MCNYFY2025 · Dec 31, 2025Common Stock (Book)
353.52MCNYFY2025 · Dec 31, 2025Retained Earnings
-137.17MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.50BCNY224.35M · vs all stocks (USD)
52-Week Low
7.20CNYUpdated Sep 18, 202652-Week High
15.63CNYUpdated Sep 18, 202652-Week Change
-30.97%vs all stocks
Beta
0.4270xvs all stocks
50-Day MA
8.69CNYUpdated Sep 18, 2026200-Day MA
10.16CNYUpdated Sep 18, 2026Avg 10-Day Volume
11.94MSharesUpdated Sep 18, 2026Avg 30-Day Volume
21.98MSharesUpdated Sep 18, 2026Diluted EPS (TTM)
-0.6000CNYUpdated Sep 18, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.50Profit Margin: -0.23
Financial Health
Altman Z-Score 2.84: safe zoneNotable
Altman Z-Score: 2.84
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Csg Holding Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hua Eng Wire & Cable Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Zhejiang Jianye Chemical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Core Laboratories Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Yes Optoelectronics Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Endur ASA
Tier 1ProductionThroughput-Bound ConversionFlowRule
NACL Industries Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Hangzhou CNCR-IT Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Sato Holdings Corporation
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Jiangsu Teeyer Intelligent Equipment Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow